Graphene Oxide Nanosheets with Efficient Antibacterial Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA)

2021 ◽  
Vol 17 (8) ◽  
pp. 1627-1634
Author(s):  
Yujie Gao ◽  
Yuanhao Dong ◽  
Yubin Cao ◽  
Wenlong Huang ◽  
Chenhao Yu ◽  
...  

The development of drug-resistant bacteria has become a public health problem, among which methicillin-resistant Staphylococcus aureus (MRSA) leads to various life-threatening diseases. Graphene oxide (GO) is a two-dimensional nanomaterial with potential in the anti-MRSA treatment. This study prepared GO nanosheets with fixed lamellar size, investigated its antibacterial activity against MRSA, and analyzed the related antibacterial mechanisms. We found that the fabrication of GO with stable dispersion was workable. Furthermore, such GO had superior antibacterial performance against MRSA at low concentrations with the dose-dependent anti-MRSA effect. The GO-MRSA interaction also provided fundamental support for the antibacterial mechanisms with cleavage and encapsulation effects. In conclusion, GO nanosheets may be a promising antimicrobial agent against MRSA.

PLoS ONE ◽  
2021 ◽  
Vol 16 (10) ◽  
pp. e0258607
Author(s):  
Shivankar Agrawal ◽  
Jusna Nandeibam ◽  
Indira Sarangthem

Staphylococcus aureus and Methicillin-resistant S. aureus (MRSA) remains one of the major concerns of healthcare associated and community-onset infections worldwide. The number of cases of treatment failure for infections associated with resistant bacteria is on the rise, due to the decreasing efficacy of current antibiotics. Notably, Acrophialophora levis, a thermophilous fungus species, showed antibacterial activity, namely against S. aureus and clinical MRSA strains. The ethyl acetate extract of culture filtrate was found to display significant activity against S. aureus and MRSA with a minimum inhibitory concentration (MIC) of 1 μg/mL and 4 μg/mL, respectively. Scanning electron micrographs demonstrated drastic changes in the cellular architecture of metabolite treated cells of S. aureus and an MRSA clinical isolate. Cell wall disruption, membrane lysis and probable leakage of cytoplasmic are hallmarks of the antibacterial effect of fungal metabolites against MRSA. The ethyl acetate extract also showed strong antioxidant activity using two different complementary free radicals scavenging methods, DPPH and ABTS with efficiency of 55% and 47% at 1 mg/mL, respectively. The total phenolic and flavonoid content was found to be 50 mg/GAE and 20 mg/CAE, respectively. More than ten metabolites from different classes were identified: phenolic acids, phenylpropanoids, sesquiterpenes, tannins, lignans and flavonoids. In conclusion, the significant antibacterial activity renders this fungal strain as a bioresource for natural compounds an interesting alternative against resistant bacteria.


2021 ◽  
Vol 56 (12) ◽  
pp. 7265-7285
Author(s):  
Shreya Kanth ◽  
Akshatha Nagaraja ◽  
Yashoda Malgar Puttaiahgowda

Abstract The current global death rate has threatened humans due to increase in deadly unknown infections caused by pathogenic microorganisms. On the contrary, the emergence of multidrug-resistant bacteria is also increasing which is leading to elevated lethality rate worldwide. Development of drug-resistant bacteria has become one of the daunting global challenges due to failure in approaching to combat against them. Methicillin-resistant Staphylococcus aureus (MRSA) is one of those drug-resistant bacteria which has led to increase in global mortality rate causing various lethal infections. Polymer synthesis can be one of the significant approaches to combat MRSA by fabricating polymeric coatings to prevent the spread of infections. This review provides last decade information in the development of various polymers against MRSA. Graphical abstract


Antibiotics ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 849
Author(s):  
Kevin Simon ◽  
Wolfgang Pier ◽  
Alex Krüttgen ◽  
Hans-Peter Horz

Methicillin-resistant Staphylococcus aureus (MRSA) is a notorious pathogen responsible for not only a number of difficult-to-treat hospital-acquired infections, but also for infections that are community- or livestock-acquired. The increasing lack of efficient antibiotics has renewed the interest in lytic bacteriophages (briefly phages) as additional antimicrobials against multi-drug resistant bacteria, including MRSA. The aim of this study was to test the hypothesis that a combination of the well-known and strictly lytic S. aureus phage Sb-1 and oxacillin, which as sole agent is ineffective against MRSA, exerts a significantly stronger bacterial reduction than either antimicrobial alone. Eighteen different MRSA isolates and, for comparison, five MSSA and four reference strains were included in this study. The bacteria were challenged with a combination of varying dosages of the phage and the antibiotic in liquid medium using five different antibiotic levels and four different viral titers (i.e., multiplicity of infections (MOIs) ranging from 10−5 to 10). The dynamics of the cell density changes were determined via time-kill assays over 16 h. Positive interactions between both antimicrobials in the form of facilitation, additive effects, or synergism were observed for most S. aureus isolates. These enhanced antibacterial effects were robust with phage MOIs of 10−1 and 10 irrespective of the antibiotic concentrations, ranging from 5 to 100 µg/mL. Neutral effects between both antimicrobials were seen only with few isolates. Importantly, antagonism was a rare exception. As a conclusion, phage Sb-1 and oxacillin constitute a robust heterologous antimicrobial pair which extends the efficacy of a phage-only approach for controlling MRSA.


2021 ◽  
Author(s):  
Xiangwen Liao ◽  
lianghong liu ◽  
yanhui Tan ◽  
guijuan jiang ◽  
haihong fang ◽  
...  

New effective antimicrobial agents with novel mode of action are urgently need due to the continued emergence of drug-resistant bacteria. Here, three ruthenium complexes functionalized with benzothiophene: [Ru(phen)2(BTPIP)](ClO4)2 (Ru(II)-1), [Ru(dmp)2(BTPIP)](ClO4)2...


2021 ◽  
Author(s):  
Akkapol Suea-Ngam ◽  
Philip D. Howes ◽  
Andrew J. deMello

An amplification-free electrochemical CRISPR/Cas biosensor utilizing silver metallization (termed E-Si-CRISPR) allows detection of methicillin-resistant Staphylococcus aureus (MRSA) with excellent sensitivity and specificity.


2021 ◽  
Vol 14 (9) ◽  
pp. 3429-3440
Author(s):  
Baudelaire Affi Kakou ◽  
Anoubile Benie ◽  
Alain Hugues N’Guessan ◽  
Konan K. Fernique ◽  
N.K. Guessennd ◽  
...  

The emergence of bacteria resistant to several families of antibiotics is nowadays a public health problem in the world. To overcome this, it appeared necessary to explore sources of active molecules from natural substances. Thus, the objective of this study was to carry out the phytochemical sorting of hydromethanol extracts from Ximenia americana stems and to evaluate their antibacterial activities on the in-vitro growth of methicillin-resistant Staphylococcus aureus. The phytochemical screening performed allowed us to identify saponins, sterols and polyterpenes, polyphenols, tannins and flavonoids. HPLC-MS/MS analysis lead to the identification of a variety of flavan-3ol, quercetin and derivatives. The study of antibacterial activity carried out on 5 multi-resistant clinical strains and on a reference strain by the Muller-Hinton agar medium diffusion and dilution method showed that the extracts were active on all the strains with MICs ranging from 6.25 to 100 mg and MBCs ranging from 12.5 to 100 mg. The antibacterial potential of these extracts highlighted in this study could make this plant a candidate for in-depth investigations that could lead to the discovery of new antibacterial molecules. L’apparition de bactéries résistantes à plusieurs familles d’antibiotiques constitue, de nos jours, un problème de santé publique dans le monde. Pour y remédier, l’exploration de sources de molécules actives à partir des substances naturelles s’est avérée nécessaire. Ainsi, l’objectif de cette étude était de réaliser le tri phytochimique des extraits hydrométhanoliques de tiges de Ximenia americana et d’évaluer leurs activités antibactériennes sur la croissance in-vitro des Staphylococcus aureus résistant à la méticilline. Le screening phytochimique réalisé a permis d’identifier des saponines, des stérols et polyterpènes, des polyphénols, des tanins et des flavonoïdes. L’analyse à la HPLC-MS/MS a permis d’identifier une variété de flavan-3ol, de la quercétine et dérivées. L’étude de l’activité antibactérienne réalisée sur 5 souches cliniques multirésistantes et sur une souche de référence par la méthode de diffusion et de dilution en milieu gélosé Muller-Hinton a montré que les extraits étaient actifs sur toutes les souches avec des CMI variant de 6,25 à 100 mg et des CMB variant de 12,5 à 100 mg. Le potentiel antibactérien de ces extraits mis en évidence dans cette étude pourrait faire de cette plante une candidate à des investigations approfondies pouvant aboutir à la découverte de nouvelles molécules antibactériennes.


2021 ◽  
Author(s):  
Jessica Bratt

<p>The spread of antibiotic resistance and the emergence of multi-drug resistant bacteria is a major threat to public health. This study investigated a unique cytosine rich DNA structure, the i-Motif to deliver soluble Ag+ as a novel antimicrobial agent (AgiMs). AgiMs were evaluated in vitro against P. aeruginosa and A. baumannii strains. AgiMs displayed significant antibacterial activity against both P. aeruginosa and A. baumannii (median MIC: 0.875 µM and 0.75 µM, respectively) by rapid, bactericidal and concentration-dependent effect. Low concentrations of AgiMs showed efficacy against PAO1 20-h biofilms, resulting in 57% reduction in biomass (5 x MIC). A single dose of AgiMs extended survival of G. Mellonella larvae, with the therapeutic benefit paralleled in the reduction of internal bacterial load. Synergistic interactions were observed with the combination of AgiMs and tobramycin, a common antibiotic used to treat P. aeruginosa infections; indicating the potential for AgiMs to reinstate the potency of current antibiotics. This silver-based agent might be an alternative to the failing antibiotic regimes for MDR resistant infections. Further in vitro and in vivo studies are warranted to confirm the therapeutic potential. </p>


2020 ◽  
Author(s):  
Miguel Martí ◽  
Alberto Tuñón-Molina ◽  
Finn Lillelund Aachmann ◽  
Yukiko Muramoto ◽  
Takeshi Noda ◽  
...  

AbstractFace masks have globally been accepted to be an effective protective tool to prevent bacterial and viral transmission, especially against indoor aerosol transmission. However, commercial face masks contain filters that are made of materials that are not capable of inactivating neither SARS-CoV-2 nor multidrug-resistant bacteria. Therefore, symptomatic and asymptomatic individuals can infect other people even if they wear them because some viable viral or bacterial loads can escape from the masks. Furthermore, viral or bacterial contact transmission can occur after touching the mask, which constitutes an increasing source of contaminated biological waste. Additionally, bacterial pathogens contribute to the SARS-CoV-2 mediated pneumonia disease complex and their resistance to antibiotics in pneumonia treatment is increasing at an alarming rate. In this regard, herein, we report the development of a novel protective non-woven face mask filter fabricated with a biofunctional coating of benzalkonium chloride that is capable of inactivating SARS-CoV-2 in one minute of contact, and the life-threatening methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Nonetheless, despite the results obtained, further studies are needed to ensure the safety and correct use of this technology for the mass production and commercialization of this broad-spectrum antimicrobial face mask filter. Our novel protective non-woven face mask filter would be useful for many health care workers and researchers working in this urgent and challenging field.


Author(s):  
M.S. Kushwaha ◽  
Anju Nayak ◽  
A.K. Rai ◽  
S. Bordoloi ◽  
V. Gupta ◽  
...  

Background: Drug resistant bacteria related health problems are major concern globally and search for newer and most effective antibacterial agents is the urgent need to combat with these challenges. The study was undertaken with the aim of isolating and identifying endophytic fungi associated with Carica papaya and assessing their potential as antibacterial agents.Methods: Carica papaya plants were collected from different locations and endophytic fungi were isolated and characterized phenotypically and genotypically by microscopy, colonial characteristics and ITS gene sequencing, respectively. Antibacterial activity of endophyte was assessed against Escherichia coli, Klebsiella pneumonia, Salmonella Typhimurium, Bacillus cereus, Staphylococcus aureus and Streptococcus pyogenes, using the agar plate diffusion assay method with Ciprofloxacin as a positive control.Result: Thirty four (34) fungal endophytes of two genera Fusarium and Penicillium were recovered from 60 samples of Carica papaya and they showed the antibacterial activity against Staphylococcus aureus. Thus, the endophytic fungi have the potential to be used as an antibacterial agent.


Author(s):  
Rongxing Chen ◽  
Huarui Xue ◽  
Yazhou Xu ◽  
Tianwei Ma ◽  
Yuan Liu ◽  
...  

Background: Methicillin-resistant S. aureus (MRSA) has already tormented humanity and the environment for a long time and is responsible for many difficult-to-treat infections. Unfortunately, there are limited therapeutic options, and MRSA isolates with complete resistance to vancomycin, the first-line drug for the treatment of MRSA infections, have already emerged in recent years. Moxifloxacin retained activity against mutant bacterial strains with various levels of fluoroquinolones resistance and had a lower potential to select for resistant mutants. Isatin is a versatile structure, and its derivatives are potent inhibitors of many enzymes and receptors. The fluoroquinolone-isatin derivatives demonstrated excellent antibacterial activity against both drug-sensitive and drug-resistant organisms. The structure-activity relationship elucidated that incorporation of 1,2,3-triazole moiety into the C-7 position of fluoroquinolone skeleton was favorable to the antibacterial activity. Accordingly, fluoroquinolone derivatives with isatin and 1,2,3-triazole fragments at the side chain on the C-7 position are promising candidates to fight against drug-resistant bacteria. Objective: To explore more active moxifloxacin derivatives to fight against MRSA and enrich the structure-activity relationships. Methods: The synthesized moxifloxacin derivatives 7a-i and 14a-f were evaluated for their antibacterial activity against a panel of MRSA strains by means of standard two-fold serial dilution method. Results: The majority of the synthesized moxifloxacin derivatives were active against most of the tested MRSA strains with MIC values in a range of 1 to 64 μg/mL. The mechanistic investigations revealed that topoisomerase IV was one of the targets for antibacterial activity. Conclusion: These derivatives are useful scaffolds for the development of novel topoisomerase IV inhibitors.


Sign in / Sign up

Export Citation Format

Share Document